Hirofumi Kuwashima

Statistics

Publications

Citations

136

H-Index

Active since

2017

Affiliations

Yokohama City University(Current)

Kanagawa Prefectural Hospital Organization

Yokohama City University Medical Center

Hiratsuka City Hospital

Hirofumi Kuwashima is an author at Yokohama City University specializing in gastrointestinal pharmacotherapy, first-line eradication therapy, and helicobacter pylori infection.

Publications per year

2017–2021

Publications

Vonoprazan‐ vs proton‐pump inhibitor‐based first‐line 7‐day triple therapy for clarithromycin‐susceptible <i>Helicobacter pylori</i>: A multicenter, prospective, randomized trial

Soichiro Sue, Marina Ogushi, Isao Arima et al. · Helicobacter · 2017 · 72 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on <i>Helicobacter pylori</i> Eradication

Soichiro Sue, Hirofumi Kuwashima, Yuri Iwata et al. · Internal Medicine · 2017 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Severe acute respiratory syndrome coronavirus 2 prevalence in saliva and gastric and intestinal fluid in patients undergoing gastrointestinal endoscopy in coronavirus disease 2019 endemic areas: Prospective cross‐sectional study in Japan

Shigeta Miyake, Keiichi Ashikari, Shingo Kato et al. · Digestive Endoscopy · 2021 · 11 citations · Full text

Medicine, Infectious Diseases, Gastroenterology +12

1–3 of 3